Publications by authors named "Ricardo Hurtado Amador"
[Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
Rafael A Sánchez-Usabiaga Mónica Aguinaga-Ríos Anaid Batista-Espinoza Ricardo Hurtado-Amador Sergio Romero-Tovar
Ginecol Obstet Mex
April 2015
Background: Recent data have shown that non invasive prenatal test (NIPT) for the detection of fetal aneuploidies (chromosomes 13, 18, 21, X, Y, and triploidy) by cell free fetal DNA in maternal blood (cfDNA) is a clinical reality, with detection rates > 99% and false positive rates of 0.1%. Results that exceed the first trimester screening.
View Article and Find Full Text PDFArticle Synopsis
- Prolactinomas are the most common type of pituitary tumor, primarily affecting women of reproductive age, with symptoms including menstrual irregularities and infertility.
- Most patients in the study displayed hyperprolactinemia, with various reproductive and hormonal issues noted before and after treatment, including hypothyroidism and hypogonadism.
- Bromocriptine treatment significantly improved symptoms and reduced prolactin levels, although some patients who had surgery experienced tumor relapse and complications like transient diabetes insipidus.
We describe herein a 38 year old male who complained of persistent cephalalgias during six months which were associated to hyperprolactinemia and a pituitary macroprolactinoma shown by MRI. The patient was treated with cabergoline (0.5 mg/week) and remained asymptomatic for a year.
View Article and Find Full Text PDF